HMGCR and neoplasm: Consistent with our findings from genetic inhibition of HMGCR, simvastatin treatment enhanced ferroptosis in immune-refractory P3 cells induced by either RSL3 or CTL-derived supernatant, as evidenced by increased levels of 7-AAD+ tumor cells and lipid ROS (Fig. 6c, d and Supplementary Fig. 15).